SlideShare ist ein Scribd-Unternehmen logo
1 von 31
Sedgwick © 2013 Confidential – Do not disclose or distribute.
Sedgwick © 2011 Confidential – Do not disclose or distribute.
JUNE 12-13, 2013
Sedgwick © 2013 Confidential – Do not disclose or distribute.
Sedgwick © 2011 Confidential – Do not disclose or distribute.
Narcotic Medication
Strategies
Teresa Bartlett, MD
Senior Vice President
Medical Quality
Sedgwick © 2013 Confidential– Do not disclose or distribute. 3Sedgwick © 2011 Confidential– Do not disclose or distribute. 3
Objectives
• Provide background information regarding opioids
• Provide education
• Provide tools to assist in the assessment of cases
• Screening tools
• Opioid Agreement
• Timing of follow up
• Board of pharmacy reporting
• Assessment considerations
• Drug Screening guidance
• Calculations of Morphine dosages
Sedgwick © 2013 Confidential– Do not disclose or distribute. 4Sedgwick © 2011 Confidential– Do not disclose or distribute. 4
Education
• First step toward Prescription Drug optimization
• Addresses:
• Overuse
• Underuse
• Misuse
• Drug to drug interactions
• Medication reconciliation process
• Overall health safety concerns
• lab studies
Sedgwick © 2013 Confidential– Do not disclose or distribute. 5Sedgwick © 2011 Confidential– Do not disclose or distribute. 5
Statistics
• Every hour in the USA one baby is born suffering from in opioid withdrawal
(NIDA)
• 40% increase in employees testing positive for prescription narcotics from
2005-2009 (Quest)
• A November 18, 2010 report post-accident drug tests are four-times more
likely to find narcotics than pre-employment drug tests (Quest)
• Vicodin is the most frequently found narcotic prescription drug
abused (Quest)
Sedgwick © 2013 Confidential– Do not disclose or distribute. 6Sedgwick © 2011 Confidential– Do not disclose or distribute. 6
Background: How did we get here
•From the American Pain Society Website:
• In late 2000, Congress passed into law a
provision, which the President signed, that
declared the ten-year period that began
January 1, 2001, as the:
• Decade of Pain Control and Research
• The American Pain Society has actively
supported the Decade of Pain Control and
Research and it has been a focal point for the
development of numerous programs to advance
awareness and treatment of pain and funding
for research
Sedgwick © 2013 Confidential– Do not disclose or distribute. 7Sedgwick © 2011 Confidential– Do not disclose or distribute. 7
Narcotic Utilization
•Fatal overdoses involving
prescribed opioids tripled in
the United States between
1999 and 2006
•A recent government study
determined that opioid poisoning was
the leading cause of death for people
aged 35-54
• This rate was higher
than motor vehicle or
firearm related deaths
for that age group
• Since 1990, the medical use of opioids has increase by a factor of 10
• According to the CDC, enough opioids were prescribed last year to
medicate every American adult with a standard pain treatment
dose of hydrocodone every 4 hours for a month
Sedgwick © 2013 Confidential– Do not disclose or distribute. 8Sedgwick © 2011 Confidential– Do not disclose or distribute. 8
Narcotic Medication Management
• National Issue
• Creates issues for
• patients
• physicians
• employers
• * The # 1 prescribed drug in the USA in 2012 was Hydrocodone
with acetaminophen (Vicodin)
http://healthland.time.com
Sedgwick © 2013 Confidential– Do not disclose or distribute. 9Sedgwick © 2011 Confidential– Do not disclose or distribute. 9
Prescription Drug Diversion as a National Issue
Sedgwick © 2013 Confidential– Do not disclose or distribute. 10Sedgwick © 2011 Confidential– Do not disclose or distribute. 10
Unintended Result
• Across the country, there is an
increase in the number of ER visits
due to non-medical use of
narcotics
• Up to 89% of abused prescription
drugs are diverted from legally
written prescriptions
Problem isn’t just with narcotic
prescribing,buthowtheyare
usedonceinthehandsofthe
public
Sedgwick © 2013 Confidential– Do not disclose or distribute. 11Sedgwick © 2011 Confidential– Do not disclose or distribute. 11
Biochemical Physiology of Narcotic Use
The way the brain reacts facilitates the process of
addiction/abuse:
• Endorphins are naturally occurring chemicals that
work on the nervous system to reduce pain
• The endorphins can act on certain parts of the brain to
produce euphoria or a natural “high”
• Addiction shuts the endorphin system down
• This leads to hyperalgia (increased pain perception)
and hypersensitivity
• The abuser then seeks higher doses or stronger drugs
Sedgwick © 2013 Confidential– Do not disclose or distribute. 12Sedgwick © 2011 Confidential– Do not disclose or distribute. 12
Opioid Guideline for Chronic Pain
• Use opioid only after other pain relief therapies have been exhausted
• Before prescribing a risk assessment screening should be conducted
• Opioids should be started at the lowest possible dose
• If a patients dosage has increased to 120mg MED without substantial
improvement in function or pain relief a chronic pain specialist should be
consulted
• Long acting or controlled release opioids should not be used for acute pain
• Fentanyl patches, OxyContin and Methadone are examples
Sedgwick © 2013 Confidential– Do not disclose or distribute. 13Sedgwick © 2011 Confidential– Do not disclose or distribute. 13
Opioid Contract
Sedgwick © 2013 Confidential– Do not disclose or distribute. 14Sedgwick © 2011 Confidential– Do not disclose or distribute. 14
Importance of Communication Skills
• Medical Literacy
• Risks
• Self Care
• Lifestyle choices
Patient
Education
• Better Results
• Transfer of specific
knowledge
Consulting
Physician
Education
BetterOutcomes
Sedgwick © 2013 Confidential– Do not disclose or distribute. 15Sedgwick © 2011 Confidential– Do not disclose or distribute. 15
Follow up Care
• Failure to progress or demonstrate functional progress or any
signs of compliance should lead to prompt discontinuance of
medication
• Dosage may need to be increased to maximize therapeutic value
not to exceed 120mg Morphine/day
• Random Urine Drug Screen
• Weaning should involve a mental health professional who
specializes in addiction
• PT, exercise and other medications such as NSAIDS are
important in this process
Sedgwick © 2013 Confidential– Do not disclose or distribute. 16Sedgwick © 2011 Confidential– Do not disclose or distribute. 16
Morphine 120mg/day is the MAXIMUM
• An electronic dose calculator can be found and downloaded
• http://agencymeddirectors.wa.gov/mobile.html
MORPHINE (reference) 30 mg
Codeine 200 mg
Fentanyl Transdermal 12.5mcg/hr
Hydrocodone (Vicodin) 30 mg
Hydromorphone 7.5mg
Oxycodone 20mg
Oxymorphone 10mg
Methadone** 4mgj BE CAUTIOUS
COMPLICATED
Sedgwick © 2013 Confidential– Do not disclose or distribute. 17Sedgwick © 2011 Confidential– Do not disclose or distribute. 17
Acetaminophen (Tylenol) Warning
• Causes liver toxicity
• Many narcotics are combined with acetaminophen so you must also watch
for maximum dosing
• Short-term use (<10 days) – 4000 mg/day
• Long-term use – 2500mg/day
Sedgwick © 2013 Confidential– Do not disclose or distribute. 18Sedgwick © 2011 Confidential– Do not disclose or distribute. 18
Opioid Risk Tool ORT
Date ______
Patient Name
OPIOID RISK TOOL
Mark each
box that applies
Item Score
If Female
Item Score
If Male
1. Family History of Substance Abuse Alcohol [ ] 1 3
Illegal Drugs [ ] 2 3
Prescription Drugs [ ] 4 4
2. Personal History of Substance Abuse Alcohol [ ] 3 3
Illegal Drugs [ ] 4 4
Prescription Drugs [ ] 5 5
3. Age (Mark box if 16 – 45) [ ] 1 1
4. History of Preadolescent Sexual Abuse [ ] 3 0
5. Psychological Disease Attention Deficit
Disorder [ ] 2 2
Obsessive Compulsive
Disorder
Bipolar
Schizophrenia
Depression [ ] 1 1
TOTAL [ ]
Total Score Risk Category Low Risk 0 – 3 Moderate Risk 4 – 7 High Risk > 8
Sedgwick © 2013 Confidential– Do not disclose or distribute. 19Sedgwick © 2011 Confidential– Do not disclose or distribute. 19
Urine Drug Testing
• Purpose
• Identify aberrant behavior
• Undisclosed drug use and/or abuse
• Verify compliance with treatment
• Frequency
• Based on risk assessment for drug abuse
• Low risk once/year
• Moderate risk twice/year
• High risk three to four times/year
• Unusual or suspicious behavior = at time of visit
• Losing prescription
• Requesting early refills
• Multiple prescribers
• Demonstrating intoxication
• Slurred, slow speech
Sedgwick © 2013 Confidential– Do not disclose or distribute. 20Sedgwick © 2011 Confidential– Do not disclose or distribute. 20
Urine Drug Testing Result Interpretation
The following UDT results should be viewed as a “red flag”
requiring confirmation and intervention:
• Negative for opioid(s) prescribed
• Positive for drug (benzodiazepines, opioids, etc) NOT prescribed
• Positive for amphetamine or methamphetamine
• Positive for alcohol
• Positive for cocaine or metabolites
If a confirmatory drug test (MRO) substantiates a “red flag” result AND is:
• Positive for prescribed opioid(s)
• a controlled taper and a referral to an addiction specialist or drug treatment
program should be considered
• Negative for prescribed opioid(s)
• The physician should stop prescribing opioid(s) and consider a referral to an
addiction specialist or drug treatment program
Sedgwick © 2013 Confidential– Do not disclose or distribute. 21Sedgwick © 2011 Confidential– Do not disclose or distribute. 21
Assessment of Function
• Overall Pain Management
• How well is the pain being managed?
• Pain rating when asked to consider the past month
• Should indicate pain is overall better and able to function at a higher
level
• Function
• Daily activities should be listed
• Even in WC activities that are healthy should be encouraged
Sedgwick © 2013 Confidential– Do not disclose or distribute. 22Sedgwick © 2011 Confidential– Do not disclose or distribute. 22
Sedgwick © 2013 Confidential– Do not disclose or distribute. 23Sedgwick © 2011 Confidential– Do not disclose or distribute. 23
Suggested Weaning Process
• Reduce Morphine mg by 10 to 20% each week
• Add Clonopine to help with withdrawal symptoms
• Addiction or Pain Management Specialist should be consulted
• May require short inpatient stay to assist with initial phase
• May require drug rehab program (inpatient and outpatient)
Sedgwick © 2013 Confidential– Do not disclose or distribute. 24Sedgwick © 2011 Confidential– Do not disclose or distribute. 24
The Role of Claim Managers
• Help the physician stay on track
• Ask for the Risk assessment (ORT) and provide tool if necessary
• Make sure other therapies are tried first
• That first RX for opioids should be small doses and improvements
should be documented in function and pain
• Request follow up assessment of patient to see if medication is working
(allergic reaction) Does not have to be office visit
• Set next appointment with treating physician for 10 to 14 days for next
assessment
• Provide an Opioid agreement to any physician prescribing these drugs
(ACOEM or State of Washington)
• Ask for copies of screening, opioid agreement, drug test results and
OARRS report
Sedgwick © 2013 Confidential– Do not disclose or distribute. 25Sedgwick © 2011 Confidential– Do not disclose or distribute. 25
Sedgwick © 2013 Confidential– Do not disclose or distribute. 26Sedgwick © 2011 Confidential– Do not disclose or distribute. 26
OHIO Automated RX Reporting System (OARRS)
• Established in 2006
• Tool to assist healthcare professionals in providing better treatment for
patients with medical needs
• Quickly identifies drug seeking behaviors.
• Prescription History Report can assure a patient is getting the appropriate
drug therapy and is taking their medication as prescribed
Who can run this history report?
• Prescribers (or delegates)
• Pharmacists
• Officers of law enforcement agencies whose primary mission involves
enforcing prescription drug laws
• All must register for an OARRS account
Sedgwick © 2013 Confidential– Do not disclose or distribute. 27Sedgwick © 2011 Confidential– Do not disclose or distribute. 27
Providers Required to Check OARRS When:
Have a drug screen result that is inconsistent with
the treatment plan or refusal to participate in a
drug screen
Forging or altering a prescription
Stealing or borrowing reported drugs
Arrest, conviction or received diversion, or
intervention in lieu of conviction for a drug related
offense while under the physician's care
Increasing the dosage of reported drugs in
amounts that exceed prescribed amount
Selling prescription drugs
Receiving reported drugs from multiple prescribers,
without clinical basis
Have a family member, friend, law enforcement
officer, or health care professional express concern
related to the patient's use of illegal or reported
drugs
Sedgwick © 2013 Confidential– Do not disclose or distribute. 28Sedgwick © 2011 Confidential– Do not disclose or distribute. 28
Potential Claim or Clinical Actions
• Focus on quality health care and patient safety issues
• Use Clinical Resources when needed:
• Customized letters to physicians
• Request drug screen
• Ask physician for contract
• Ask Physician to run OARRS Report
• Identify red flags
• Physician Peer outreach
• Independent Medical Exam
• Seek a weaning process from the treating physician
• Potential point of sale blocks
• GOAL: Improve management of the injured workers’
medication regime and lower overall claim costs
Sedgwick © 2013 Confidential– Do not disclose or distribute. 29Sedgwick © 2011 Confidential– Do not disclose or distribute. 29
Role of Pharmacy Benefit Management
• Identify adverse trends
• Provide point of sale alerts
• Customize according to need
• Define historic use and potential abuse
• Injury specific formulary
• Formulary different for acute and chronic phase
Sedgwick © 2013 Confidential– Do not disclose or distribute. 30Sedgwick © 2011 Confidential– Do not disclose or distribute. 30
Success Stories
• Sometimes well intended, high quality physicians fall prey to drug seeking patients
– Got narcotic pain RX
– Called doctor and indicated they realized they had a negative reaction in the
past asked for different RX
• Injured worker who did not want narcotics after learning they may cause erectile
dysfunction
• Injured worker who did not want to risk the side effect of the medications when
nurse explained the medication
Sedgwick © 2013 Confidential – Do not disclose or distribute.
Sedgwick © 2011 Confidential – Do not disclose or distribute.
MAKE A DIFFERENCE!
Questions and Discussion

Weitere ähnliche Inhalte

Was ist angesagt?

Outsourcing and Telemedicine: Risks and Rewards
Outsourcing and Telemedicine: Risks and RewardsOutsourcing and Telemedicine: Risks and Rewards
Outsourcing and Telemedicine: Risks and Rewards
Sedgwick
 
FlexCare Telehealth Sales Overiew
FlexCare Telehealth Sales Overiew FlexCare Telehealth Sales Overiew
FlexCare Telehealth Sales Overiew
FlexCare
 
FeelingBetterNow-ConnectivityCoordination-MentalHealth
FeelingBetterNow-ConnectivityCoordination-MentalHealthFeelingBetterNow-ConnectivityCoordination-MentalHealth
FeelingBetterNow-ConnectivityCoordination-MentalHealth
Rafi Chaudhury
 
Life Cycle of a Physician Practice
Life Cycle of a Physician PracticeLife Cycle of a Physician Practice
Life Cycle of a Physician Practice
Shannon Farr
 
Gns healthcare carol mccall
Gns healthcare   carol mccallGns healthcare   carol mccall
Gns healthcare carol mccall
mlkrgr
 
healthPERX Telehealth Brochure (2014)
healthPERX Telehealth Brochure (2014)healthPERX Telehealth Brochure (2014)
healthPERX Telehealth Brochure (2014)
weBranding
 
Q7 ethical
Q7 ethicalQ7 ethical
Q7 ethical
TEDMED
 

Was ist angesagt? (20)

Hsa 525 Massive Success / snaptutorial.com
Hsa 525 Massive Success / snaptutorial.comHsa 525 Massive Success / snaptutorial.com
Hsa 525 Massive Success / snaptutorial.com
 
HSA 525 EXceptional Education/snaptutorial.COM
HSA 525 EXceptional Education/snaptutorial.COMHSA 525 EXceptional Education/snaptutorial.COM
HSA 525 EXceptional Education/snaptutorial.COM
 
Hsa 525 Education Specialist -snaptutorial.com
Hsa 525   Education Specialist -snaptutorial.comHsa 525   Education Specialist -snaptutorial.com
Hsa 525 Education Specialist -snaptutorial.com
 
Maine HR Summit 2010- Rules for Wellness Programs
Maine HR Summit 2010- Rules for Wellness ProgramsMaine HR Summit 2010- Rules for Wellness Programs
Maine HR Summit 2010- Rules for Wellness Programs
 
Mynd presentation 6/3/2019
Mynd presentation 6/3/2019Mynd presentation 6/3/2019
Mynd presentation 6/3/2019
 
Presentation All Benefits 10 10 10
Presentation   All Benefits 10 10 10Presentation   All Benefits 10 10 10
Presentation All Benefits 10 10 10
 
Outsourcing and Telemedicine: Risks and Rewards
Outsourcing and Telemedicine: Risks and RewardsOutsourcing and Telemedicine: Risks and Rewards
Outsourcing and Telemedicine: Risks and Rewards
 
FlexCare Telehealth Sales Overiew
FlexCare Telehealth Sales Overiew FlexCare Telehealth Sales Overiew
FlexCare Telehealth Sales Overiew
 
FLAACOs 2014 Conference - Reducing Fragmentation in Post-Acute Care: A Citra ...
FLAACOs 2014 Conference - Reducing Fragmentation in Post-Acute Care: A Citra ...FLAACOs 2014 Conference - Reducing Fragmentation in Post-Acute Care: A Citra ...
FLAACOs 2014 Conference - Reducing Fragmentation in Post-Acute Care: A Citra ...
 
FeelingBetterNow-ConnectivityCoordination-MentalHealth
FeelingBetterNow-ConnectivityCoordination-MentalHealthFeelingBetterNow-ConnectivityCoordination-MentalHealth
FeelingBetterNow-ConnectivityCoordination-MentalHealth
 
Life Cycle of a Physician Practice
Life Cycle of a Physician PracticeLife Cycle of a Physician Practice
Life Cycle of a Physician Practice
 
Integration Changes Everything: Communication, Collaboration, Patient Flow, ...
 Integration Changes Everything: Communication, Collaboration, Patient Flow, ... Integration Changes Everything: Communication, Collaboration, Patient Flow, ...
Integration Changes Everything: Communication, Collaboration, Patient Flow, ...
 
Gns healthcare carol mccall
Gns healthcare   carol mccallGns healthcare   carol mccall
Gns healthcare carol mccall
 
Digital Engagement of ED Patients 4-18-16
Digital Engagement of ED Patients 4-18-16Digital Engagement of ED Patients 4-18-16
Digital Engagement of ED Patients 4-18-16
 
healthPERX Telehealth Brochure (2014)
healthPERX Telehealth Brochure (2014)healthPERX Telehealth Brochure (2014)
healthPERX Telehealth Brochure (2014)
 
Q7 ethical
Q7 ethicalQ7 ethical
Q7 ethical
 
ROI of wellness programs - Optimity webinar series Dec 2016
ROI of wellness programs - Optimity webinar series Dec 2016ROI of wellness programs - Optimity webinar series Dec 2016
ROI of wellness programs - Optimity webinar series Dec 2016
 
The Surprising ROI of Employee Wellness
The Surprising ROI of Employee WellnessThe Surprising ROI of Employee Wellness
The Surprising ROI of Employee Wellness
 
OPERATIONAL INTEGRATION: CREATING A HIGH-PERFORMING HEALTHCARE ORGANIZATION
OPERATIONAL INTEGRATION: CREATING A HIGH-PERFORMING HEALTHCARE ORGANIZATIONOPERATIONAL INTEGRATION: CREATING A HIGH-PERFORMING HEALTHCARE ORGANIZATION
OPERATIONAL INTEGRATION: CREATING A HIGH-PERFORMING HEALTHCARE ORGANIZATION
 
Pekin Presentation
Pekin PresentationPekin Presentation
Pekin Presentation
 

Andere mochten auch

Meat celia, alba, alberto)
Meat celia, alba, alberto)Meat celia, alba, alberto)
Meat celia, alba, alberto)
IES La Azucarera
 
Technological process
Technological processTechnological process
Technological process
Lupe2000
 
I attached both High & Low res PDF's H
I attached both High & Low res PDF's HI attached both High & Low res PDF's H
I attached both High & Low res PDF's H
Christine Krivosheiw
 
Odissea: la Maga Circe
Odissea: la Maga CirceOdissea: la Maga Circe
Odissea: la Maga Circe
baldopi66
 

Andere mochten auch (20)

Mega Dams - Belo Monte - Christian Poirier
Mega Dams - Belo Monte - Christian PoirierMega Dams - Belo Monte - Christian Poirier
Mega Dams - Belo Monte - Christian Poirier
 
Unit 7 lessons 1 2 as a pwrpt
Unit 7 lessons 1 2 as a pwrptUnit 7 lessons 1 2 as a pwrpt
Unit 7 lessons 1 2 as a pwrpt
 
Meat celia, alba, alberto)
Meat celia, alba, alberto)Meat celia, alba, alberto)
Meat celia, alba, alberto)
 
Technological process
Technological processTechnological process
Technological process
 
Summer traning report
Summer traning reportSummer traning report
Summer traning report
 
Brochure party-time
Brochure party-timeBrochure party-time
Brochure party-time
 
I attached both High & Low res PDF's H
I attached both High & Low res PDF's HI attached both High & Low res PDF's H
I attached both High & Low res PDF's H
 
Hipertensão arterial na mulher
Hipertensão arterial na mulherHipertensão arterial na mulher
Hipertensão arterial na mulher
 
Climate Crimes - Geoingeneering
Climate Crimes - GeoingeneeringClimate Crimes - Geoingeneering
Climate Crimes - Geoingeneering
 
Titulos
TitulosTitulos
Titulos
 
Anfitriones folleto digital
Anfitriones folleto digitalAnfitriones folleto digital
Anfitriones folleto digital
 
W20160121160738807 6000151230 03-14-2016_081828_am_sesion 5 - cis
W20160121160738807 6000151230 03-14-2016_081828_am_sesion 5 - cisW20160121160738807 6000151230 03-14-2016_081828_am_sesion 5 - cis
W20160121160738807 6000151230 03-14-2016_081828_am_sesion 5 - cis
 
7 клас. 1-3 урок. Архітектура. Інтерєр (теорія)
7 клас. 1-3 урок. Архітектура. Інтерєр (теорія)7 клас. 1-3 урок. Архітектура. Інтерєр (теорія)
7 клас. 1-3 урок. Архітектура. Інтерєр (теорія)
 
Foto corso sci
Foto corso sciFoto corso sci
Foto corso sci
 
Hippies
HippiesHippies
Hippies
 
Parto en presentacion podalica
Parto en presentacion podalicaParto en presentacion podalica
Parto en presentacion podalica
 
Alimentazione
AlimentazioneAlimentazione
Alimentazione
 
Pubblicazione maggiodef 2 (2)
Pubblicazione maggiodef 2 (2)Pubblicazione maggiodef 2 (2)
Pubblicazione maggiodef 2 (2)
 
Numero 2 di aprile
Numero 2 di aprileNumero 2 di aprile
Numero 2 di aprile
 
Odissea: la Maga Circe
Odissea: la Maga CirceOdissea: la Maga Circe
Odissea: la Maga Circe
 

Ähnlich wie Ohio Self-Insurers Association 2013

Training innovations dual diagnosis cambian fountains march 16
Training innovations dual diagnosis cambian fountains march 16Training innovations dual diagnosis cambian fountains march 16
Training innovations dual diagnosis cambian fountains march 16
Patrick Doyle
 
Reducing Antipsychotic Drug Use for Dementia
Reducing Antipsychotic Drug Use for DementiaReducing Antipsychotic Drug Use for Dementia
Reducing Antipsychotic Drug Use for Dementia
LeadingAge
 

Ähnlich wie Ohio Self-Insurers Association 2013 (20)

Getting the low down on prescription opioids: Learn how to notice the signs a...
Getting the low down on prescription opioids: Learn how to notice the signs a...Getting the low down on prescription opioids: Learn how to notice the signs a...
Getting the low down on prescription opioids: Learn how to notice the signs a...
 
Know Your Drugs
Know Your DrugsKnow Your Drugs
Know Your Drugs
 
The Opioid Epidemic - N Elkins
The Opioid Epidemic - N ElkinsThe Opioid Epidemic - N Elkins
The Opioid Epidemic - N Elkins
 
Module 3: Prevention, Screening, Referral, & Treatment
Module 3: Prevention, Screening, Referral, & TreatmentModule 3: Prevention, Screening, Referral, & Treatment
Module 3: Prevention, Screening, Referral, & Treatment
 
Training innovations dual diagnosis cambian fountains march 16
Training innovations dual diagnosis cambian fountains march 16Training innovations dual diagnosis cambian fountains march 16
Training innovations dual diagnosis cambian fountains march 16
 
Mental Health Policy - Psychotropic Drugs
Mental Health Policy - Psychotropic DrugsMental Health Policy - Psychotropic Drugs
Mental Health Policy - Psychotropic Drugs
 
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conoverRx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
 
At risk young people and drug abuse in WA
At risk young people and drug abuse in WAAt risk young people and drug abuse in WA
At risk young people and drug abuse in WA
 
Reducing Antipsychotic Drug Use for Dementia
Reducing Antipsychotic Drug Use for DementiaReducing Antipsychotic Drug Use for Dementia
Reducing Antipsychotic Drug Use for Dementia
 
Drug abuse & addiction
Drug abuse & addictionDrug abuse & addiction
Drug abuse & addiction
 
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency DepartmentTackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
 
Opoid used disorder
Opoid used disorderOpoid used disorder
Opoid used disorder
 
Aiming for a Higher Performing Health Care System: Learning from Cross-Nation...
Aiming for a Higher Performing Health Care System: Learning from Cross-Nation...Aiming for a Higher Performing Health Care System: Learning from Cross-Nation...
Aiming for a Higher Performing Health Care System: Learning from Cross-Nation...
 
Rx15 clinical wed_1230_1_moskowitz_2hall
Rx15 clinical wed_1230_1_moskowitz_2hallRx15 clinical wed_1230_1_moskowitz_2hall
Rx15 clinical wed_1230_1_moskowitz_2hall
 
Decide treatment - a new approach to better health
Decide treatment - a new approach to better healthDecide treatment - a new approach to better health
Decide treatment - a new approach to better health
 
Week 1-sbirt-attc-workwise-series (1)
Week 1-sbirt-attc-workwise-series (1)Week 1-sbirt-attc-workwise-series (1)
Week 1-sbirt-attc-workwise-series (1)
 
Prescription opioids and the opiate epidemic
Prescription opioids and the opiate epidemicPrescription opioids and the opiate epidemic
Prescription opioids and the opiate epidemic
 
Embargo version rx15_tt_wed_300_zibbell
Embargo version rx15_tt_wed_300_zibbellEmbargo version rx15_tt_wed_300_zibbell
Embargo version rx15_tt_wed_300_zibbell
 
FMCC 2016 Curbing Rx Drug Abuse Plenary by Sarah Chouinard
FMCC 2016 Curbing Rx Drug Abuse Plenary by Sarah ChouinardFMCC 2016 Curbing Rx Drug Abuse Plenary by Sarah Chouinard
FMCC 2016 Curbing Rx Drug Abuse Plenary by Sarah Chouinard
 
Learning Disabilities: Share and Learn webinar - 26 May 2016
Learning Disabilities: Share and Learn webinar - 26 May 2016Learning Disabilities: Share and Learn webinar - 26 May 2016
Learning Disabilities: Share and Learn webinar - 26 May 2016
 

Mehr von Sedgwick

I-Spy: How Social networking is impacting claims investigations
I-Spy: How Social networking is impacting claims investigationsI-Spy: How Social networking is impacting claims investigations
I-Spy: How Social networking is impacting claims investigations
Sedgwick
 

Mehr von Sedgwick (11)

Stress in the workplace Blog Series
Stress in the workplace Blog SeriesStress in the workplace Blog Series
Stress in the workplace Blog Series
 
The Impact of FMLA and ADA Compliance on Employers
The Impact of FMLA and ADA Compliance on EmployersThe Impact of FMLA and ADA Compliance on Employers
The Impact of FMLA and ADA Compliance on Employers
 
Midlevel Operations: Exploring New Expsoures with Allied Health Providers
Midlevel Operations: Exploring New Expsoures with Allied Health ProvidersMidlevel Operations: Exploring New Expsoures with Allied Health Providers
Midlevel Operations: Exploring New Expsoures with Allied Health Providers
 
Better With Age: Strengthening Your Workforce and Productivity
Better With Age: Strengthening Your Workforce and Productivity Better With Age: Strengthening Your Workforce and Productivity
Better With Age: Strengthening Your Workforce and Productivity
 
Absence Management Express DMEC April, 2013
Absence Management Express DMEC April, 2013Absence Management Express DMEC April, 2013
Absence Management Express DMEC April, 2013
 
Maximizing Electronic Health Record Use in Physician Practices to Minimize Risk
Maximizing Electronic Health Record Use in Physician Practices to Minimize RiskMaximizing Electronic Health Record Use in Physician Practices to Minimize Risk
Maximizing Electronic Health Record Use in Physician Practices to Minimize Risk
 
I-Spy: How Social networking is impacting claims investigations
I-Spy: How Social networking is impacting claims investigationsI-Spy: How Social networking is impacting claims investigations
I-Spy: How Social networking is impacting claims investigations
 
Solving the Professional Liability Puzzle with the Right Pieces
Solving the Professional Liability Puzzle with the Right PiecesSolving the Professional Liability Puzzle with the Right Pieces
Solving the Professional Liability Puzzle with the Right Pieces
 
Actuaries and Examiners Talk Numbers: Go Figure!
Actuaries and Examiners Talk Numbers:  Go Figure!Actuaries and Examiners Talk Numbers:  Go Figure!
Actuaries and Examiners Talk Numbers: Go Figure!
 
Fundamentals of Claims Management
Fundamentals of Claims ManagementFundamentals of Claims Management
Fundamentals of Claims Management
 
Order in the Court: Litigation Management Strategies
Order in the Court: Litigation Management StrategiesOrder in the Court: Litigation Management Strategies
Order in the Court: Litigation Management Strategies
 

Kürzlich hochgeladen

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 

Kürzlich hochgeladen (20)

General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Plant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxPlant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptx
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 

Ohio Self-Insurers Association 2013

  • 1. Sedgwick © 2013 Confidential – Do not disclose or distribute. Sedgwick © 2011 Confidential – Do not disclose or distribute. JUNE 12-13, 2013
  • 2. Sedgwick © 2013 Confidential – Do not disclose or distribute. Sedgwick © 2011 Confidential – Do not disclose or distribute. Narcotic Medication Strategies Teresa Bartlett, MD Senior Vice President Medical Quality
  • 3. Sedgwick © 2013 Confidential– Do not disclose or distribute. 3Sedgwick © 2011 Confidential– Do not disclose or distribute. 3 Objectives • Provide background information regarding opioids • Provide education • Provide tools to assist in the assessment of cases • Screening tools • Opioid Agreement • Timing of follow up • Board of pharmacy reporting • Assessment considerations • Drug Screening guidance • Calculations of Morphine dosages
  • 4. Sedgwick © 2013 Confidential– Do not disclose or distribute. 4Sedgwick © 2011 Confidential– Do not disclose or distribute. 4 Education • First step toward Prescription Drug optimization • Addresses: • Overuse • Underuse • Misuse • Drug to drug interactions • Medication reconciliation process • Overall health safety concerns • lab studies
  • 5. Sedgwick © 2013 Confidential– Do not disclose or distribute. 5Sedgwick © 2011 Confidential– Do not disclose or distribute. 5 Statistics • Every hour in the USA one baby is born suffering from in opioid withdrawal (NIDA) • 40% increase in employees testing positive for prescription narcotics from 2005-2009 (Quest) • A November 18, 2010 report post-accident drug tests are four-times more likely to find narcotics than pre-employment drug tests (Quest) • Vicodin is the most frequently found narcotic prescription drug abused (Quest)
  • 6. Sedgwick © 2013 Confidential– Do not disclose or distribute. 6Sedgwick © 2011 Confidential– Do not disclose or distribute. 6 Background: How did we get here •From the American Pain Society Website: • In late 2000, Congress passed into law a provision, which the President signed, that declared the ten-year period that began January 1, 2001, as the: • Decade of Pain Control and Research • The American Pain Society has actively supported the Decade of Pain Control and Research and it has been a focal point for the development of numerous programs to advance awareness and treatment of pain and funding for research
  • 7. Sedgwick © 2013 Confidential– Do not disclose or distribute. 7Sedgwick © 2011 Confidential– Do not disclose or distribute. 7 Narcotic Utilization •Fatal overdoses involving prescribed opioids tripled in the United States between 1999 and 2006 •A recent government study determined that opioid poisoning was the leading cause of death for people aged 35-54 • This rate was higher than motor vehicle or firearm related deaths for that age group • Since 1990, the medical use of opioids has increase by a factor of 10 • According to the CDC, enough opioids were prescribed last year to medicate every American adult with a standard pain treatment dose of hydrocodone every 4 hours for a month
  • 8. Sedgwick © 2013 Confidential– Do not disclose or distribute. 8Sedgwick © 2011 Confidential– Do not disclose or distribute. 8 Narcotic Medication Management • National Issue • Creates issues for • patients • physicians • employers • * The # 1 prescribed drug in the USA in 2012 was Hydrocodone with acetaminophen (Vicodin) http://healthland.time.com
  • 9. Sedgwick © 2013 Confidential– Do not disclose or distribute. 9Sedgwick © 2011 Confidential– Do not disclose or distribute. 9 Prescription Drug Diversion as a National Issue
  • 10. Sedgwick © 2013 Confidential– Do not disclose or distribute. 10Sedgwick © 2011 Confidential– Do not disclose or distribute. 10 Unintended Result • Across the country, there is an increase in the number of ER visits due to non-medical use of narcotics • Up to 89% of abused prescription drugs are diverted from legally written prescriptions Problem isn’t just with narcotic prescribing,buthowtheyare usedonceinthehandsofthe public
  • 11. Sedgwick © 2013 Confidential– Do not disclose or distribute. 11Sedgwick © 2011 Confidential– Do not disclose or distribute. 11 Biochemical Physiology of Narcotic Use The way the brain reacts facilitates the process of addiction/abuse: • Endorphins are naturally occurring chemicals that work on the nervous system to reduce pain • The endorphins can act on certain parts of the brain to produce euphoria or a natural “high” • Addiction shuts the endorphin system down • This leads to hyperalgia (increased pain perception) and hypersensitivity • The abuser then seeks higher doses or stronger drugs
  • 12. Sedgwick © 2013 Confidential– Do not disclose or distribute. 12Sedgwick © 2011 Confidential– Do not disclose or distribute. 12 Opioid Guideline for Chronic Pain • Use opioid only after other pain relief therapies have been exhausted • Before prescribing a risk assessment screening should be conducted • Opioids should be started at the lowest possible dose • If a patients dosage has increased to 120mg MED without substantial improvement in function or pain relief a chronic pain specialist should be consulted • Long acting or controlled release opioids should not be used for acute pain • Fentanyl patches, OxyContin and Methadone are examples
  • 13. Sedgwick © 2013 Confidential– Do not disclose or distribute. 13Sedgwick © 2011 Confidential– Do not disclose or distribute. 13 Opioid Contract
  • 14. Sedgwick © 2013 Confidential– Do not disclose or distribute. 14Sedgwick © 2011 Confidential– Do not disclose or distribute. 14 Importance of Communication Skills • Medical Literacy • Risks • Self Care • Lifestyle choices Patient Education • Better Results • Transfer of specific knowledge Consulting Physician Education BetterOutcomes
  • 15. Sedgwick © 2013 Confidential– Do not disclose or distribute. 15Sedgwick © 2011 Confidential– Do not disclose or distribute. 15 Follow up Care • Failure to progress or demonstrate functional progress or any signs of compliance should lead to prompt discontinuance of medication • Dosage may need to be increased to maximize therapeutic value not to exceed 120mg Morphine/day • Random Urine Drug Screen • Weaning should involve a mental health professional who specializes in addiction • PT, exercise and other medications such as NSAIDS are important in this process
  • 16. Sedgwick © 2013 Confidential– Do not disclose or distribute. 16Sedgwick © 2011 Confidential– Do not disclose or distribute. 16 Morphine 120mg/day is the MAXIMUM • An electronic dose calculator can be found and downloaded • http://agencymeddirectors.wa.gov/mobile.html MORPHINE (reference) 30 mg Codeine 200 mg Fentanyl Transdermal 12.5mcg/hr Hydrocodone (Vicodin) 30 mg Hydromorphone 7.5mg Oxycodone 20mg Oxymorphone 10mg Methadone** 4mgj BE CAUTIOUS COMPLICATED
  • 17. Sedgwick © 2013 Confidential– Do not disclose or distribute. 17Sedgwick © 2011 Confidential– Do not disclose or distribute. 17 Acetaminophen (Tylenol) Warning • Causes liver toxicity • Many narcotics are combined with acetaminophen so you must also watch for maximum dosing • Short-term use (<10 days) – 4000 mg/day • Long-term use – 2500mg/day
  • 18. Sedgwick © 2013 Confidential– Do not disclose or distribute. 18Sedgwick © 2011 Confidential– Do not disclose or distribute. 18 Opioid Risk Tool ORT Date ______ Patient Name OPIOID RISK TOOL Mark each box that applies Item Score If Female Item Score If Male 1. Family History of Substance Abuse Alcohol [ ] 1 3 Illegal Drugs [ ] 2 3 Prescription Drugs [ ] 4 4 2. Personal History of Substance Abuse Alcohol [ ] 3 3 Illegal Drugs [ ] 4 4 Prescription Drugs [ ] 5 5 3. Age (Mark box if 16 – 45) [ ] 1 1 4. History of Preadolescent Sexual Abuse [ ] 3 0 5. Psychological Disease Attention Deficit Disorder [ ] 2 2 Obsessive Compulsive Disorder Bipolar Schizophrenia Depression [ ] 1 1 TOTAL [ ] Total Score Risk Category Low Risk 0 – 3 Moderate Risk 4 – 7 High Risk > 8
  • 19. Sedgwick © 2013 Confidential– Do not disclose or distribute. 19Sedgwick © 2011 Confidential– Do not disclose or distribute. 19 Urine Drug Testing • Purpose • Identify aberrant behavior • Undisclosed drug use and/or abuse • Verify compliance with treatment • Frequency • Based on risk assessment for drug abuse • Low risk once/year • Moderate risk twice/year • High risk three to four times/year • Unusual or suspicious behavior = at time of visit • Losing prescription • Requesting early refills • Multiple prescribers • Demonstrating intoxication • Slurred, slow speech
  • 20. Sedgwick © 2013 Confidential– Do not disclose or distribute. 20Sedgwick © 2011 Confidential– Do not disclose or distribute. 20 Urine Drug Testing Result Interpretation The following UDT results should be viewed as a “red flag” requiring confirmation and intervention: • Negative for opioid(s) prescribed • Positive for drug (benzodiazepines, opioids, etc) NOT prescribed • Positive for amphetamine or methamphetamine • Positive for alcohol • Positive for cocaine or metabolites If a confirmatory drug test (MRO) substantiates a “red flag” result AND is: • Positive for prescribed opioid(s) • a controlled taper and a referral to an addiction specialist or drug treatment program should be considered • Negative for prescribed opioid(s) • The physician should stop prescribing opioid(s) and consider a referral to an addiction specialist or drug treatment program
  • 21. Sedgwick © 2013 Confidential– Do not disclose or distribute. 21Sedgwick © 2011 Confidential– Do not disclose or distribute. 21 Assessment of Function • Overall Pain Management • How well is the pain being managed? • Pain rating when asked to consider the past month • Should indicate pain is overall better and able to function at a higher level • Function • Daily activities should be listed • Even in WC activities that are healthy should be encouraged
  • 22. Sedgwick © 2013 Confidential– Do not disclose or distribute. 22Sedgwick © 2011 Confidential– Do not disclose or distribute. 22
  • 23. Sedgwick © 2013 Confidential– Do not disclose or distribute. 23Sedgwick © 2011 Confidential– Do not disclose or distribute. 23 Suggested Weaning Process • Reduce Morphine mg by 10 to 20% each week • Add Clonopine to help with withdrawal symptoms • Addiction or Pain Management Specialist should be consulted • May require short inpatient stay to assist with initial phase • May require drug rehab program (inpatient and outpatient)
  • 24. Sedgwick © 2013 Confidential– Do not disclose or distribute. 24Sedgwick © 2011 Confidential– Do not disclose or distribute. 24 The Role of Claim Managers • Help the physician stay on track • Ask for the Risk assessment (ORT) and provide tool if necessary • Make sure other therapies are tried first • That first RX for opioids should be small doses and improvements should be documented in function and pain • Request follow up assessment of patient to see if medication is working (allergic reaction) Does not have to be office visit • Set next appointment with treating physician for 10 to 14 days for next assessment • Provide an Opioid agreement to any physician prescribing these drugs (ACOEM or State of Washington) • Ask for copies of screening, opioid agreement, drug test results and OARRS report
  • 25. Sedgwick © 2013 Confidential– Do not disclose or distribute. 25Sedgwick © 2011 Confidential– Do not disclose or distribute. 25
  • 26. Sedgwick © 2013 Confidential– Do not disclose or distribute. 26Sedgwick © 2011 Confidential– Do not disclose or distribute. 26 OHIO Automated RX Reporting System (OARRS) • Established in 2006 • Tool to assist healthcare professionals in providing better treatment for patients with medical needs • Quickly identifies drug seeking behaviors. • Prescription History Report can assure a patient is getting the appropriate drug therapy and is taking their medication as prescribed Who can run this history report? • Prescribers (or delegates) • Pharmacists • Officers of law enforcement agencies whose primary mission involves enforcing prescription drug laws • All must register for an OARRS account
  • 27. Sedgwick © 2013 Confidential– Do not disclose or distribute. 27Sedgwick © 2011 Confidential– Do not disclose or distribute. 27 Providers Required to Check OARRS When: Have a drug screen result that is inconsistent with the treatment plan or refusal to participate in a drug screen Forging or altering a prescription Stealing or borrowing reported drugs Arrest, conviction or received diversion, or intervention in lieu of conviction for a drug related offense while under the physician's care Increasing the dosage of reported drugs in amounts that exceed prescribed amount Selling prescription drugs Receiving reported drugs from multiple prescribers, without clinical basis Have a family member, friend, law enforcement officer, or health care professional express concern related to the patient's use of illegal or reported drugs
  • 28. Sedgwick © 2013 Confidential– Do not disclose or distribute. 28Sedgwick © 2011 Confidential– Do not disclose or distribute. 28 Potential Claim or Clinical Actions • Focus on quality health care and patient safety issues • Use Clinical Resources when needed: • Customized letters to physicians • Request drug screen • Ask physician for contract • Ask Physician to run OARRS Report • Identify red flags • Physician Peer outreach • Independent Medical Exam • Seek a weaning process from the treating physician • Potential point of sale blocks • GOAL: Improve management of the injured workers’ medication regime and lower overall claim costs
  • 29. Sedgwick © 2013 Confidential– Do not disclose or distribute. 29Sedgwick © 2011 Confidential– Do not disclose or distribute. 29 Role of Pharmacy Benefit Management • Identify adverse trends • Provide point of sale alerts • Customize according to need • Define historic use and potential abuse • Injury specific formulary • Formulary different for acute and chronic phase
  • 30. Sedgwick © 2013 Confidential– Do not disclose or distribute. 30Sedgwick © 2011 Confidential– Do not disclose or distribute. 30 Success Stories • Sometimes well intended, high quality physicians fall prey to drug seeking patients – Got narcotic pain RX – Called doctor and indicated they realized they had a negative reaction in the past asked for different RX • Injured worker who did not want narcotics after learning they may cause erectile dysfunction • Injured worker who did not want to risk the side effect of the medications when nurse explained the medication
  • 31. Sedgwick © 2013 Confidential – Do not disclose or distribute. Sedgwick © 2011 Confidential – Do not disclose or distribute. MAKE A DIFFERENCE! Questions and Discussion